Normal view MARC view ISBD view

[Loss of teeth and aid offering dental prostheses to the population in Bulgaria]. [electronic resource]

By:

STILIIANOV, G

Contributor(s):

Producer: 20030501Description: 116-25 p. digitalISSN:

0491-0982

Subject(s):

In: Stomatologiia. Stomatology vol. 2

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1321 Fluctuation of tPA and PAI-1 antigen levels in plasma: difference of their fluctuation patterns between male and female.
by Urano, T
1322 Thrombolysis for pulmonary embolism.
by Goldhaber, S Z
1323 Construction of a tissue plasminogen activator gene having unique restriction sites to facilitate domain manipulation: a model for the analysis of multi-domain proteins.
by Rehberg, E F
1324 Commonly asked questions concerning thrombolytic therapy.
by Breed, J
1325 Thrombolytic therapy for acute myocardial infarction.
by Haley, F L
1326 Rapid resolution of pulmonary embolism by tissue plasminogen activator.
by Intenzo, C M
1327 Clot-selective thrombolysis: the impact of tissue-type plasminogen activator (t-PA) in thromboembolic diseases.
by Bounameaux, H
1328 Immunohistochemical localization of plasminogen activators in human saphenous veins.
by Risberg, B
1329 Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine.
by Hanss, M
1330 Linkage analysis of peripheral neurofibromatosis to DNA markers on chromosome 8.
by Diehl, S R
1331 Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivo.
by Runge, M S
1332 Fibrinolytic activity in medium from tissue culture of paranasal mucous membrane.
by Kosugi, T
1333 The influence of the fibrinolytic system on the affinity of fibrinogen for the endothelial-plasma interface.
by Witte, S
1334 Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis.
by Jordan, J M
1335 Thrombolytic therapy orders and record sheets: nursing care made easier.
by Rafter, R H
1336 Normal but not hypertriglyceridemic very low-density lipoprotein induces rapid release of tissue plasminogen activator from cultured human umbilical vein endothelial cells.
by Booyse, F M
1337 [Are the publicized advantages of thrombolytic treatment of myocardial infarct with recombinant t-PA (ACTILYSE) in comparison with streptokinase so decisive, that despite the high cost a general use of ACTILYSE is justified?].
by Gulba, D C
1338 [Seborrheic keratoses. Intact epidermal differentiation despite disordered morphogenesis].
by Wollina, U
1339 Front-loaded accelerated infusions of tissue plasminogen activator: putting a better foot forward.
by Vaughan, D E
1340 Variable depletion of endogenous factor XII-dependent fibrinolytic activity following thrombolytic therapy of myocardial infarction and its relation to reinfarction.
by Kluft, C